This year brought a lot of twists and turns for investors. It began on an optimistic note as the new President, Donald Trump, ...

Trading today has little resemblance to what it was even a decade ago. Powerful digital tools have become the go-to ...

For speculators intrigued by discounts among blue-chip giants, healthcare juggernaut AbbVie (ABBV) is well worth ...

The education market in the United States is shifting its focus from a traditional approach to a more digitalized one, mainly ...

Return on equity (ROE) is one of the most favored metrics of investors. It is a profitability ratio that measures earnings generated by a company from its equity. Investors can follow the ROE trend in ...

Periods of explosive market optimism don’t arrive quietly. They build fast, and convince even cautious investors that “this ...

Fidelity is one of the most recognizable names in retirement planning. As I write this, Fidelity boasts more than 52 million ...

Tech stocks came under serious selling pressure on Friday with the market concerned about Oracle’s (ORCL) debt issuance and ...

Costs of Care and The Leapfrog Group today announced that Jeffrey A. Flaks, President and Chief Executive Officer of Hartford ...

Stocks were trying to fight back following Friday's negative session. The Dow rose fractionally. Goldman Sachs GS and Amgen ...

The U.S. stock markets ended the week mostly lower, with the tech-heavy Nasdaq Composite and the S&P 500 slipping by 1.49% ...